Clients News • MC Services corporate website
5522
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

CLIENT NEWS

 

 

  • Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) in this Round
    29 July 2021
    www.topas-therapeutics.com
  • AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
    27 July 2021
    www.affiris.com
  • Abivax announces the pricing of its oversubscribed capital increase of EUR 60M and convertible bonds of EUR 25M, totaling EUR 85M new financing
    23 July 2021
    www.relieftherapeutics.com
  • XPhyto signs transformative acquisition agreement with 3a-diagnostics, to enter hi-tech biosensor market and expand its diagnostic product portfolio
    20 July 2021
    www.xphyto.com
  • es Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib
    19 July 2021
    www.redhillbio.com
  • Marinomed Biotech AG announces grant of Chinese Patent covering the proprietary Marinosolv technology to generate aqueous solutions from insoluble compounds
    15 July 2021
    www.marinomed.com
  • Avisa Diagnostics to Participate at Upcoming Investor Events
    09 July 2021
    www.avisapharma.com
  • AiCuris starts its first pivotal clinical phase 3 trial with pritelivir for the treatment of herpes simplex virus infections in immunocompromised subjects based on efficacy and safety data from a phase 2 trial
    08 July 2021
    www.aicuris.com
  • Diaccurate introduces its world-leading scientific advisory board
    08 July 2021
    www.diaccurate.com
  • APEIRON Biologics launches next clinical trial with innovative cancer therapy APN401
    06 July 2021
    www.apeiron-biologics.com